Skip to main content

Diversification by entry into a new submarket?

Buy Article:

$53.17 plus tax (Refund Policy)

Abstract:

Using a dataset on the subsector and geographical segmentation of 208 Pharmaceutical companies, a Bayesian panel probit is used to analyze the role of state dependency, size and achieved diversification in affecting entry decision. We properly account for unobservable heterogeneity in a context with nonstrictly exogenous regressors. We find that achieved diversification, measured by the number of submarkets already entered affects negatively the probability of entry. Beside some country-specific exceptions, size and the lagged dependent variable do not seem to be relevant.

Keywords: Bayesian inference; C11; C23; C25; L11; L65; diversification; entry; panel data; probit model; random effects

Document Type: Research Article

DOI: http://dx.doi.org/10.1080/00036846.2011.628297

Affiliations: 1: DG-Research, European Central Bank, Dipartimento di Scienze Economiche,Università di Brescia, Brescia, Italy 2: Dipartimento di Economia,Management e Metodi Quantitativi, Università degli Studi di Milano, Milano, Italy

Publication date: April 1, 2013

More about this publication?
routledg/raef/2013/00000045/00000012/art00002
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more